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Abstract
Background: Prostate cancer is the most common male cancer in the Western world. The most
substantial long term morbidity from this cancer is sexual dysfunction with consequent adverse
changes in couple and intimate relationships. Research to date has not identified an effective way
to improve sexual and psychosocial adjustment for both men with prostate cancer and their
partners. As well, the efficacy and cost effectiveness of peer counselling as opposed to professional
models of service delivery has not yet been empirically tested. This paper presents the design of a
three arm randomised controlled trial (peer vs. nurse counselling vs. usual care) that will evaluate
the efficacy of two couples-based sexuality interventions (ProsCan for Couples: Peer support vs.
nurse counselling) on men's and women's sexual and psychosocial adjustment after surgical
treatment for localised prostate cancer; in addition to cost-effectiveness.
Methods/design: Seventy couples per condition (210 couples in total) will be recruited after
diagnosis and before treatment through urology private practices and hospital outpatient clinics and
randomised to (1) usual care; (2) eight sessions of peer-delivered telephone support with DVD
education; and (3) eight sessions of oncology nurse-delivered telephone counselling with DVD
education. Two intervention sessions will be delivered before surgery and six over the six months
post-surgery. The intervention will utilise a cognitive behavioural approach along with couple
relationship education focussed on relationship enhancement and helping the couple to conjointly
manage the stresses of cancer diagnosis and treatment. Participants will be assessed at baseline
(before surgery) and 3, 6 and 12 months post-surgery. Outcome measures include: sexual
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adjustment; unmet sexuality supportive care needs; attitudes to sexual help seeking; psychological
adjustment; benefit finding and quality of life.
Discussion: The study will provide recommendations about the efficacy of peer support vs. nurse
counselling to facilitate better sexual and couple adjustment after prostate cancer as well as
recommendations on whether the interventions represent efficient health service delivery.
Trial Registration: ACTRN12608000358347
Background
The context of prostate cancer
Prostate cancer is the most common male cancer and sec-
ond most common cause of cancer death in men in the
Western world (excluding non melanoma skin cancer). In
Australia, 1 in 11 men will be diagnosed with prostate
cancer in their lifetime (0–74 years) and 1 in 82 will die
from the disease [1]. In 2003 there were 13,526 Australian
men diagnosed with prostate cancer with this number
expected to increase to over 18,000 for 2006 [2].
Improved survival from prostate cancer has been demon-
strated worldwide [3]. Around half of all newly diagnosed
men are predicted to be alive 15 years after diagnosis [3]
such that the large cohort of men living with the conse-
quences of diagnosis and treatment is increasing.
The most frequently received treatment for prostate cancer
in Australia is radical prostatectomy and the predomi-
nance of radical prostatectomy as the primary treatment
approach for this cancer is mirrored elsewhere such as in
North America [4,5]. While sexual dysfunction after all
treatment approaches is common, the trajectory of this
dysfunction and severity varies by treatment modality [6].
Men treated with radiation therapy experience less erectile
dysfunction (ED) initially following treatment however,
in contrast to radical prostatectomy, function is more
likely decline over time. In addition, many men now
receive neo-adjuvant hormone therapy with radiotherapy,
further complicating the course of their sexual adjust-
ment. For radical prostatectomy early adjuvant hormone
therapy is uncommon and ED will be immediate due to
surgical damage to the neurovascular bundle that lies
adjacent to the prostate, with some improvement over the
two years after surgery [7]. However, even with nerve spar-
ing surgical techniques that aim to reduce damage to erec-
tile function as few as 18.5% of men report being able to
achieve erections firm enough for sexual intercourse two
years after surgery [6,7]. Compared with their age mates,
men with prostate cancer have a 10 to 15 fold increase in
ED [8]. Other distressing effects of treatment include:
penile shortening (68% of men), loss of sexual desire
(60–80%), less satisfying orgasms (64–87%), overall sex-
ual dissatisfaction (61–91%) [9,10]. These effects can lead
to: impaired sexual performance; changes in relationships
with women and sexual partners; lost enjoyment of sexual
imaginings; decrements in masculine self esteem [10,11].
Problematically, many men are reluctant to seek help for
sexual difficulties, with only about half of men seeking
medical treatment for ED up to five years after treatment
[10]. Reluctance to seek help is particularly problematic
for men who receive radical prostatectomy as, for these
men, an early return to sexual activity (by three months
after surgery) may increase the recovery rate of spontane-
ous erections and improve responses to ED treatments
[12]. Thus, support services for men with prostate cancer
that are targeted to sexuality concerns need to reach men
who receive radical prostatectomy within weeks of their
cancer treatment.
Sexual dysfunction is a shared problem within couples,
with regret and loss common among both members of the
couple [13]. However, existing medical and support serv-
ices for men with prostate cancer are oriented towards the
patient, do not pay sufficient attention to the couple rela-
tionship and virtually ignore the needs of female partners
of these men. Partners are more likely to focus on building
their husband's self-esteem and putting the sexual dys-
function into perspective within the relationship, and less
likely to focus on their own sexual needs [14]. Partners'
quality of life is related to their reports of sexual function
within the relationship and sexual dysfunction has impli-
cations for the longer-term psychosocial well-being of
partners [15]. Women often are less focused on finding
'mechanical' treatments to regain erectile function and
more open to counseling that might assist the couple to
experience intimacy and closeness even if intercourse is
not possible [16]. The attention to improving erectile
rigidity in the man, for which 'mechanical' treatments are
usually needed, may overshadow the partner's needs for
sexual pleasure and stimulation [17].
The psychological distress of female partners is increased
if they have limited knowledge of what to expect during
the course of their husband's treatment and after care, and
unmet supportive care needs are often reported. Female
partners may be reluctant to share their distress with their
husband in order to minimize the stress of the illness on
the couple's experience; and may avoid discussing issues
that create emotional tension, such as sexual concerns
[14]. This lack of communication means that partnersBMC Cancer 2008, 8:226 http://www.biomedcentral.com/1471-2407/8/226
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often have to deal with their distress and anxiety alone
with limited opportunities for psychosocial care [18]. The
distress experienced by partners is exacerbated by their
husbands' reliance on them for emotional support, with
partners having to manage not only their own anxiety, but
also the distress of their husbands [14].
Protecting one's partner from emotional distress may
have significant costs to one's own well being and dimin-
ish relationship quality over time [19]. Patients' and part-
ners' abilities to cope with prostate cancer and subsequent
treatment side-effects are interrelated [20] and can nega-
tively impact on the marital relationship [21]. The reac-
tions of partners to sexual dysfunction and the support
they provide appears to affect the level of acceptance of
sexual changes experienced by men [22]. As well, the
female partner's ability to still enjoy sex without major
dysfunction is a strong predictor of better sexual satisfac-
tion in the male partner [10]. The disparate needs of cou-
ples experiencing sexual dysfunction highlights the need
to provide couples with targeted support that promotes
communication and adjustment to sexual outcomes. In
work with couples in which the woman had breast or
gynecological cancer, enhancing couple communication
and conjoint coping with cancer treatments significantly
enhanced women's sexual satisfaction [23]. Moreover,
this couple focused approach increased couple discussion
of cancer related issues, and reduced the unhelpful ten-
dency of some people to avoid discussion. In a similar
manner, it is proposed that attending to the couple rela-
tionship, promoting a sense of conjoint coping and
addressing sexual needs within the relationship, will
enhance both partners' adjustment to prostate cancer and
increase the chance of adherence and better sexual out-
comes including erectile function.
Approaches to Intervention Delivery
By contrast to women, men are less likely to seek help for
psychological distress; are under-represented as clients to
cancer support services; are reluctant to utilise effective
sexual aids after prostate cancer treatment despite high lev-
els of dissatisfaction with the sexual outcomes of treat-
ment. Effective support interventions need to utilise
delivery methods and sources that are acceptable to this
patient group. Men and their partners prefer individual
consultations for sexuality support after prostate cancer
[16]. Tele-delivered interventions are highly acceptable to
this group, and web/computer based programs are fre-
quently accessed by men for medical and procedural
information [24,25]. Remote access delivery methods
overcome geographical barriers to access and so are appli-
cable to geographically dispersed populations with high
potential for population-based translation.
A source of support that has high uptake amongst men
with prostate cancer in Australia and internationally is
peer support, with men reporting that peer discussions
provide informational and emotional support and reduce
feelings of social isolation [26]. A feasibility study of a
dyadic peer support program for men with prostate cancer
reported reduced depression and improved self efficacy in
the short term, with men most frequently discussing
incontinence, erectile dysfunction and Prostate-Specific
Antigen testing with their matched peers [27]. As well, a
randomised controlled trial of a group education program
to assist men to adjust to prostate cancer treatments [28]
found that only by adding peer discussion to the provi-
sion of information by an expert was sexual bother allevi-
ated significantly, relative to a control group. An
advantage of peer support that is provided by veteran
patients is that it is inexpensive by comparison to profes-
sionally delivered approaches, such as specialist nurses.
While this approach is highly promising, to date ran-
domised controlled trials to assess the effectiveness of
peer support in improving men's adjustment have not
been undertaken. However, based on research to date a
peer delivered counselling intervention paired with edu-
cation may have equal efficacy to health professional
delivery. As well, the relative cost savings for a peer sup-
port approach as compared to professional approaches,
although not yet quantified, make this a potentially cost
effective source of support.
Intervention Studies Targeting Sexuality
To date intervention research targeting sexuality after
prostate cancer is scant. Two trials noted improvements in
sexual satisfaction, but not functioning, following general
psycho-educational interventions [24,28]. These studies
were limited by not including the man's partner [24,28];
not targeting men early in the cancer treatment contin-
uum [28]; and not controlling for type of cancer treatment
[24,28]. One of the only intervention studies to focus spe-
cifically on improving sexual function was a randomized
trial comparing four face-to-face couple counselling ses-
sions to similar sessions for the man alone, with the
female partner just reading educational material and col-
laborating with homework tasks [17]. Men and their part-
ners in both conditions reported improved sexual
function and satisfaction at three month follow up and
increased utilisation of medical treatments for ED at three
and six months; gains in sexual function diminished at six
months. Study limitations included low statistical power
from a small sample size and that as men were an average
of 27 to 30 months post-treatment at baseline, the critical
opportunity for early intervention was missed. As well,
face-to-face delivery method is relatively expensive, hard
to access, and difficult to translate into a population-
based cost-effective approach.
We propose that greater attention to the couple relation-
ship in the intervention would improve female sexual or
couple relationship satisfaction. Moreover, given theBMC Cancer 2008, 8:226 http://www.biomedcentral.com/1471-2407/8/226
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strong association between sexual and relationship satis-
faction, particularly for women [29], enhancing the cou-
ple relationship is likely to improve long-term
maintenance of sexual satisfaction improvements.
Methods/Design
Study Aims and Hypotheses
The overall study aim is to compare the efficacy of peer-
delivered telephone support with DVD educational
resource, vs. oncology nurse-delivered telephone counsel-
ling with DVD educational resource, vs. usual care in
improving both men's and women's sexual and psychoso-
cial adjustment at 3, 6 and 12 months after treatment for
localised prostate cancer. In doing so we will also compare
the cost-effectiveness of support by trained peers vs. nurse
counsellors; and identify demographic, medical and psy-
chosocial variables that predict improvement in psycho-
sexual adjustment in prostate cancer patients and their
partners with each intervention approach.
The intervention will utilise a cognitive behavioural
approach that has been found to be effective in promoting
positive adjustment after cancer [30], along with couple
relationship education focussed on relationship enhance-
ment and helping the couple to conjointly manage the
stresses of cancer diagnosis and treatment [19]. The study
will have three arms: (1) usual care (2) telephone support
by a trained male peer support volunteer who is a prostate
cancer survivor with DVD education and (3) oncology
nurse-delivered telephone counselling with DVD educa-
tion.
It is hypothesised that 3, 6, and 12 months after surgery
for localised prostate cancer:
1. By contrast to couples in usual care, couples who
receive either the peer or nurse delivered intervention will
have a more positive sexual adjustment; lower unmet sex-
uality supportive care needs; more positive attitudes to
sexual help seeking; higher uptake of erectile aids;
improved psychological adjustment and quality of life.
2. Couples who receive the peer and nurse delivered inter-
vention will have similar sexual adjustment; sexuality sup-
portive care needs; attitudes to sexual help seeking; uptake
of erectile aids; psychological adjustment and quality of
life.
3. The peer delivered intervention will be more cost effec-
tive by comparison to the nurse delivered intervention.
Intervention
Usual care will consist of the man's standard medical
management and existing written educational materials.
For the two intervention arms, the eight sessions of phone
support/counselling will include enhanced couple com-
munication and conjoint coping content and material rel-
evant to the early treatment phase. An audiovisual DVD
resource with Tip Sheets will accompany the intervention
to enhance the psycho-education and sexuality education
components and to also provide actor role models for
effective couple communication about sexuality and inti-
macy. The nurse counselling sessions will follow princi-
ples of cognitive-behavioural sex and marital therapy and
will utilise an adult learning approach in which partners'
self-select goals to focus on while working through the
program. Content includes education about prostate can-
cer, menopause, and sexuality; assigned behavioural
homework including increasing expression of affection
and non-demanding sexual touch; challenging negative
beliefs about prostate cancer, aging, and sexuality; and
helping the couple choose a medical treatment for ED that
is acceptable to both partners, and integrating this into
their sexual relationship. Additional components that tar-
get the challenges of the early treatment phase (e.g., uri-
nary incontinence, pain, sleep disturbance, psychological
distress) will be additionally selected by the couple if rel-
evant.
Peer support is based on the support partner or 'veteran'
patient having personal experience and knowledge about
the cancer experience; a unique personal insight into
effective ways to cope; and the ability to form a support
relationship that is derived from the connection of shared
experience. In this way peer support can reduce feelings of
isolation and stigma (the sense of being the 'only one');
can convey emotional, social, informational and practical
support; and through role modelling can communicate
realistic hope and optimism about the future. Peer sup-
port volunteers will be prostate cancer survivors who are
at least 12 months post treatment and who have support
group experience. The intervention will follow the same
couples-based approach as the nurse counselling inter-
vention but will be oriented to empathic mutual support
and education rather than in depth sex and marital ther-
apy.
The patient's partner will be invited to participate in all
phone sessions, and actual participation will be recorded
by the peer/therapist for each phone session, as well as
minutes of counselling time, for inclusion in analyses.
Support/counselling calls are timed to correspond with
the challenges associated with preparing for and recover-
ing from radical prostatectomy. The first two calls will
occur prior to surgery; four fortnightly calls (Sessions 3 to
6) are timed to commence two weeks after surgery; a fur-
ther two calls (Session 7 to 8) 16 and 22 weeks post-sur-
gery.
Participants
With the strong endorsement and support of Queensland
Urologists, patients will be referred to the project from
private urology practices and public hospital outpatient
clinics in Queensland, Australia. Informed written con-BMC Cancer 2008, 8:226 http://www.biomedcentral.com/1471-2407/8/226
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sent will be obtained by study trained research nurses who
will contact potential participants after referral to the
study. We will recruit 70 couples per condition over a 12
month period (allowing for 10% attrition from treatment;
210 couples in total to be recruited). Assuming a moder-
ate effect size of d = 0.5, alpha at .05, the resulting power
with 70 couples per condition is 0.8. Inclusion criteria are
that the men must: (1) have been newly diagnosed with
localised prostate cancer and have chosen radical prosta-
tectomy as their treatment approach (2) be currently in a
heterosexual cohabitating couple relationship (3) be able
to read and speak English (4) have no previous history of
head injury, dementia or psychiatric illness (5) have no
other concurrent cancer. As the intervention has been
developed based on previous data for heterosexual cou-
ples this intervention is unlikely to be helpful for homo-
sexual couples.
Study Integrity
Ethical approval has been obtained from the Griffith Uni-
versity Human Research Ethics Committee. The study
design will be guided by the CONSORT statement [31].
Randomisation to study condition will occur following
the completion of baseline assessment. Assessments will
be by self-report pen and paper measures and project staff
tracking assessments will be blinded to condition. Ran-
domisation will occur in blocks of 12, with each condi-
tion randomly generated 4 times within each block to
ensure an unpredictable allocation sequence with equal
numbers of couples in each group at the completion of
each block. This sequence will be undertaken by the
project manager and concealed from investigators. Ther-
apy will be manualised and all intervention calls audio-
taped with 25% reviewed to ensure treatment adherence.
All analyses will be conducted on the basis of intention to
treat.
Measures
A series of previously validated and reliable self report
measures will be administered by mail. Domain specific
quality of life (QOL) will be included as a potential mod-
erator of intervention effect and challenge appraisals and
therapeutic alliance as mediators. Primary outcomes are:
sexual adjustment; unmet sexual supportive care needs;
masculine self-esteem; marital satisfaction; utilisation of
erectile aids. Secondary outcomes are: psychological dis-
tress; overall QOL and benefit finding. Disease variables
(e.g. cancer grade, stage) will be assessed through medical
and cancer registry records review. Use of medical services




The International Prostate Symptom Score [32] and the
urinary and bowel symptom subscales of the UCLA Pros-
tate Cancer Index [33] will assess disease specific QOL.
Women will complete a menopausal symptom scale
derived from the Breast Cancer Prevention Trial (BCPT)
Symptom Checklist [34].
Challenge appraisal
A person's cognitive appraisal of an event will determine
if that event is perceived as stressful and this will be
assessed using a Stress Appraisal Measure based on the
work of Roesch [35].
Therapeutic alliance
The quality of the bond between the peer and nurse coun-
sellors and the couple and extent of agreement about ther-




Men will complete the International Index of Erectile
Functioning (IIEF) [37], which allows sexual function to
be assessed in five domains: erectile function, orgasmic
function, sexual desire, intercourse satisfaction and over-
all sexual satisfaction. Women will complete the Female
Sexual Function Index (FSFI) [38]. This questionnaire par-
allels the IIEF and examines sexual function among
women in six domains: sexual desire, arousal, lubrication,
orgasm, satisfaction, and pain.
Sexual Supportive Care Needs
Couples needs related to sexual relationships will be
assessed using the sexuality needs subscale of the Support-
ive Care Needs Survey [39,40].
Sexual Self-Confidence
The Short Form Psychological and Interpersonal Relation-
ship Scale (SF-PAIRS) [41] will assess sexual confidence
and spontaneity associated with ED.
Masculine Self-Esteem
The Masculine Self-Esteem scale will assess men's
appraisal of their masculinity [42].
Utilisation of sexual aids
A scale developed by Schover [43] will assess whether men
have obtained medical help for sexual dysfunction and
the impact of each treatment on their sex life.
Marital satisfaction
An abbreviated version of the Dyadic Adjustment Scale




The Hospital Anxiety and Depression Scale [45] will pro-
vide a global measure of current psychological distress
with subscale scores for anxiety and depression.BMC Cancer 2008, 8:226 http://www.biomedcentral.com/1471-2407/8/226
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Quality of Life
Health related quality of life will be assessed with the SF-
36, the most widely used QOL measure in the world with
norms for the Australian general population available.
The SF-36 [46] contains a mental health and physical
health summary scale to measure the impact of the inter-
vention on patients' and partners' wellbeing.
Benefit Finding
Benefit finding [47] will be used to measure the perceived
positive experiences and outcomes (eg appreciation of
life, changes in life priorities) resulting from the diagnosis
of cancer.
Statistical Analyses
The study hypotheses will be tested by multilevel model-
ling (MLM). This class of procedures is the appropriate
way to analyse hierarchical data sets such as the longitudi-
nal data of the proposed research in which observations
are nested within persons who in turn are nested within
couples. Study condition is modelled as a fixed effect at
the couple level. The typical RCT effects that have been
tested by ANOVAs are all available with MLM; however
there are several fundamental differences between the sta-
tistical models. First, in MLM individual and couple tra-
jectories of change in time can be modelled directly as
random effects. This provides appropriate tests of Hypoth-
eses 1 and 2 and allows precise examination of predictors
of individual versus group change. Second, MLM mini-
mises the loss of data through attrition in that unlike
ANOVA all available data points from participants are
included in analyses. The direct ML estimation normally
used in MLM is currently the most favoured technique
(along with multiple imputation) for minimising bias
and enhancing precision in parameter estimates from
incomplete data [48]. Hypotheses 1 and 2 will be tested
with appropriate contrasts on the fixed effect of study con-
dition. Although power calculations from multilevel lon-
gitudinal analyses are not as well articulated as for older
techniques, the study will have at least as much power as
the equivalent ANOVA (i.e., 80% for a moderate effect
size;) as the intervention effects are all based upon the
level 3 (i.e., couple) sample size.
A cost-utility analysis will also be undertaken to address
Hypothesis 3 where intervention resources and health
outcomes are combined in an analysis to produce infor-
mation on the relative economic efficiency between the
peer, nurse specialist and usual care options. The analysis
will take the perspectives of the health provider and
health system and involve the assessment of 1) cost data
on resources used in each of the three arms by identifying,
quantifying and valuing resources using standard meth-
ods and, 2) health outcomes, in terms of quality-adjusted
life years (QALYs). Using Medicare Australia data, we also
wish to capture health utilisation costs for GP visits and
medication use to assess whether the interventions change
typical health care use. Quality of life will be measured in
participants using the preference-based utility instrument
SF-6D [49] which is based on the SF-36 quality of life tool.
The key outcome for the cost-utility analysis will be the
incremental cost-effectiveness ratio, expressed as the incre-
mental cost per QALY. This ratio represents the difference
in costs between the intervention and usual care options
divided by the difference in QALYs gained across the two
options. This means that it is the additional cost and health
benefits of each of the two interventions over and above
what occurs in usual care that is important. Secondary
economic endpoints will include incremental cost-effec-
tiveness ratios for cost per % gain in sexual function and
psychological distress. A Bayesian statistical approach to
the analysis will be followed so that probabilistic state-
ments on the efficiency of the intervention will be pro-
duced [50]. Data will be analysed using the computer
program TreeAge Pro (Healthcare Module) 2005 [51]. The
results will be scrutinised using probabilistic sensitivity
analysis which is standard practice in economic evalua-
tions to address data uncertainty and potentially strength-
ens the generalisability of the results. Specifically, Monte
Carlo simulations will produce cost-effectiveness accepta-
bility curves and probabilistic statements on cost-effec-
tiveness.
Discussion
This study will address a critical but as yet unanswered
research question: to identify a cost-effective and popula-
tion based approach to promoting optimal psychosexual
adjustment for men with prostate cancer and their part-
ners. To date, for this patient group, no sexuality interven-
tion studies have: targeted couples at diagnosis when
distress is highest; been adequately powered to look dif-
ferentially at intervention effects; trialled peer support; or
included economic analyses. This research will overcome
these limitations. The intervention will be able to be uti-
lised by trained nurses in a range of settings including
broad reach tele-health lines and also through peer sup-
port programs that are conducted internationally. This
means that project outputs will be immediately translata-
ble into practice to improve the sexual health and overall
well-being of men with prostate cancer and their partners.
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